Imugene tweeted 13 Mar
Another ground breaking publication from Imugene's City of Hope colleagues led by Professor Yuman Fong. Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and is difficult to treat. The study shows that CF33-hNIS-ΔF14.5 (VAXinia) favourably modulates the tumour immune microenvironment in TNBC models making them responsive to immune checkpoint inhibitors and hence warrants further studies to determine the clinical applicability of this combination therapy. VAXinia will enter a Phase 1 clinical trial in 2020.
https://www.ncbi.nlm.nih.gov/pubmed...CRJgV3ji8tpsgq1r22wipvdNNE0uI6LE1YDF3fqZVJfLc
- Forums
- ASX - By Stock
- LC Wholesale Investor Presentation
Imugene tweeted 13 Mar Another ground breaking publication from...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M |
Open | High | Low | Value | Volume |
4.9¢ | 5.2¢ | 4.9¢ | $531.4K | 10.66M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 3429444 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 149299 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 3429444 | 0.049 |
101 | 13614489 | 0.048 |
59 | 6705081 | 0.047 |
32 | 4464036 | 0.046 |
55 | 5142720 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 149299 | 2 |
0.051 | 1338894 | 8 |
0.052 | 1380788 | 9 |
0.053 | 1765338 | 11 |
0.054 | 3316349 | 14 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |